Curtis Lockshin

Curtis Lockshin is a seasoned professional in the biotechnology and pharmaceuticals sectors, currently serving as Vice President of Research & Operations at Xenetic Biosciences, Inc. since March 2014 and as President & CEO of Guardum Pharmaceuticals, LLC since May 2013. With extensive experience as Director at the Ruth K. Broad Biomedical Research Foundation and past roles including Chief Executive Officer at SciVac Ltd. and VP of Corporate R&D Initiatives at OPKO Health, Inc., Curtis Lockshin has a proven track record in drug discovery and leadership. Academic credentials include a PhD in Biological Chemistry and an S.B. in Life Sciences, both from the Massachusetts Institute of Technology.